乳酸左氧氟沙星治疗女性泌尿生殖道衣原体及衣原体合并淋菌感染

Observation of the clinical efficacy of levofloxacin lactate in the treatment of female′s urinary and genital tracts infections of chlamyolia and chlamydia with gonococcus

观察乳酸左氧氟沙星 (L VL XL)治疗女性泌尿生殖道衣原体及衣原体合并淋菌感染的疗效。观察组 10 0例 ,其中单纯衣原体感染 6 0例 ,衣原体合并淋菌感染 40例 ,门诊治疗 70例 ,应用 L VL XL2 0 0 mg,po,bid,住院治疗 30例 ,10 0 mg,ivgtt,bid/ 2 0 0 mg,po,qn。对照组 35例衣原体合并淋菌感染 ,门诊治疗 17例 ,住院治疗 18例 ,应用头孢曲松 /红霉素治疗。以上病人治疗疗程均为 7d。结果 :观察组与对照组临床有效率分别为 95 %和97% ,两组对比无显著差异。不良反应分别为 14%和 49% ,有显著差异。结论 :L VL XL 治疗女性泌尿生殖道衣原体及衣原体合并淋菌感染疗效可靠 ,不良反应少 ,可作为临床首选药物之一。

To observe levofloxacin lactate′s therapeutic effect in female′s urinary and genital tracts infection of chlamydia and chlamydia with gonococcus. The levofloxacin group has 100 cases including 60 cases infected by chlamydia and 40 cases infected by chlamydia with gonococcus. 70 cases were outpatients given levofloxacin lactate tablets 200mg twice a day, per os; 30 cases were inpatients given intravenous transfusion 100mg twice a day and tablets 200mg at night. Comparision group has 35 cases infected by chlamydia with gonococcus, including 17 outpatients and 18 inpatients. They were treated with ceftriaxone and erythromycin. All patients were treated for 7 days. The effective rates of levofloxacin and comparision group were 95% and 97% respectively. No statistically significant differences were observed. The adverse reaction rates of the two groups were 14% and 49% respectively, there was significant difference. Levofloxacin lactate has reliable clinical efficacy which could be the first choice in treating female′s urinary and genital tracts infections of chlamydia and chlamydia with gonococcus.